South Texas Clinical Laboratory LTD

South Texas Clinical Laboratory LTD was paid $424K by Medicaid between Jan 2018 and Oct 2024, across 97 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 13% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Texas

Rank by total paid#99 of 436

Median peer was paid$17K

This provider vs. median25×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	56,351	$3K
2019	91,856	$5K
2020	87,618	$50K
2021	91,162	$108K
2022	93,305	$120K
2023	92,063	$81K
2024incomplete	61,762	$57K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	13%	6,506	3,311	$54K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	12%	70,879	51,118	$51K
80053	Comprehensive metabolic panel	11%	55,891	43,801	$48K
80050	General health panel	8.7%	1,789	1,678	$37K
80061	Lipid panel	5.6%	20,891	19,660	$24K
83036	Hemoglobin; glycosylated (A1C)	4.5%	23,393	21,762	$19K
80048	Basic metabolic panel (calcium, ionized)	3.3%	16,802	11,305	$14K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	2.9%	251	241	$12K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	2.7%	5,985	5,325	$11K
87086	Culture, bacterial; quantitative colony count, urine	2.3%	17,765	15,749	$10K
G2024	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source	2.2%	2,088	1,507	$10K
87186		2.0%	14,081	12,133	$8K

85 more codes

80177		1.9%	6,315	$8K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	1.8%	1,355	$8K
87077		1.8%	13,523	$8K
84443	Thyroid stimulating hormone (TSH)	1.8%	17,638	$8K
83880		1.7%	2,662	$7K
83735		1.7%	6,770	$7K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	1.6%	354	$7K
87088		1.6%	12,313	$7K
82140		1.5%	4,385	$6K
80164		1.3%	5,811	$6K
P9603	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled	<1%	88,763	$4K
84134		<1%	2,906	$4K
82607		<1%	3,445	$3K
84100		<1%	3,439	$3K
80185		<1%	3,149	$3K
80202		<1%	488	$3K
87070		<1%	2,879	$3K
81001		<1%	11,602	$2K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	677	$2K
84481		<1%	1,424	$2K
86141		<1%	1,130	$2K
82746		<1%	1,781	$2K
82728		<1%	2,107	$2K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	171	$2K
84439		<1%	1,948	$1K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	69	$1K
84436		<1%	3,284	$1K
85610		<1%	5,001	$1K
85651		<1%	1,038	$998.14
83550		<1%	1,683	$978.76
82274		<1%	953	$947.83
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	57	$925.15
83540		<1%	1,995	$897.05
81003		<1%	6,455	$836.70
87205		<1%	1,269	$823.94
86480		<1%	79	$814.39
87493		<1%	302	$753.08
83970		<1%	263	$736.11
84479		<1%	1,809	$670.94
80069		<1%	1,547	$645.13
84480		<1%	1,524	$461.57
82248		<1%	1,277	$442.06
80076		<1%	1,664	$379.83
85379		<1%	271	$354.23
G0471	Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha)	<1%	71,895	$337.17
80156		<1%	252	$336.13
82570		<1%	1,307	$281.16
82652		<1%	133	$261.68
80162		<1%	960	$214.30
87040		<1%	134	$203.52
87660		<1%	22	$184.41
87340		<1%	43	$141.88
87480		<1%	27	$128.25
99001		<1%	224	$127.01
87510		<1%	28	$109.53
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	181	$102.66
87147		<1%	286	$100.49
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	119	$77.69
84550		<1%	348	$77.65
82043		<1%	627	$63.52
87634		<1%	95	$58.97
36415	Collection of venous blood by venipuncture	<1%	26,830	$55.86
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	166	$48.30
85730		<1%	207	$39.93
84153		<1%	42	$38.64
80184		<1%	87	$34.83
84156		<1%	83	$33.90
84132		<1%	548	$33.84
82565		<1%	176	$29.02
86592		<1%	12	$24.56
82947		<1%	320	$12.21
86901		<1%	12	$9.41
86900		<1%	12	$9.41
85652		<1%	79	$7.56
85018		<1%	365	$3.57
85014		<1%	365	$3.57
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	0%	14	$0.00
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	0%	16	$0.00
86769		0%	12	$0.00
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	0%	3,992	$0.00
84155		0%	13	$0.00
83721		0%	18	$0.00
85007		0%	80	$0.00
85049		0%	79	$0.00
87631		0%	12	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSANDERS, ANDREW (PARTNER)